Trade

with

AxoGen Inc
(NASDAQ: AXGN)
AdChoices
2.58
+0.06
+2.38%
After Hours :
-
-
-

Open

2.57

Previous Close

2.52

Volume (Avg)

24.98k (41.11k)

Day's Range

2.43-2.60

52Wk Range

2.11-5.20

Market Cap.

45.06M

Dividend Rate ( Yield )

-

Beta

0.47

Shares Outstanding

17.47M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 10.95M

    • Net Income

    • -14.56M

    • Market Cap.

    • 45.06M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -117.66

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.47

    • Forward P/E

    • -4.30

    • Price/Sales

    • 3.23

    • Price/Book Value

    • -6.28

    • Price/Cash flow

    • -4.40

      • EBITDA

      • -9.42M

      • Return on Capital %

      • -82.18

      • Return on Equity %

      • -

      • Return on Assets %

      • -82.18

      • Book Value/Share

      • -0.41

      • Shares Outstanding

      • 17.47M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.06 (2/23/2005)

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 5.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.60

        • Cashflow Estimate

        • -0.49

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 47.20

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 172.61

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 78.67

            • 64.08

            • Pre-Tax Margin

            • -117.66

            • 15.19

            • Net Profit Margin

            • -117.66

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 80.40

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -369.70

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 8.99

              • 2.55

              • Quick Ratio

              • 7.41

              • 1.83

              • Interest Coverage

              • -1.95

              • 11.70

              • Leverage Ratio

              • -

              • 1.86

              • Book Value/Share

              • -0.41

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -3.10

                • 34.01

                • P/E Ratio 5-Year High

                • -6.71

                • 224.03

                • P/E Ratio 5-Year Low

                • 0.00

                • 60.23

                • Price/Sales Ratio

                • 3.64

                • 3.17

                • Price/Book Value

                • -7.08

                • 3.20

                • Price/Cash Flow Ratio

                • -4.40

                • 18.42

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 0.00

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • 2/23/2005

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -

                        (-)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -82.18

                        (-9.00)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -

                        (-)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • 0.81

                      • 2.77

                      • Asset Turnover

                      • 0.70

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -9.59M
                      Operating Margin
                      -87.62
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -4.40
                      Ownership

                      Institutional Ownership

                      23.96%

                      Top 10 Institutions

                      27.03%

                      Mutual Fund Ownership

                      1.35%

                      Float

                      84.70%

                      5% / Insider Ownership

                      14.15%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        151,348

                      • 0.00

                      • 0.87

                      • Thomson Horstmann & Bryant Microcap Fund

                      •  

                        68,360

                      • 0.23

                      • 0.39

                      • Vanguard Extended Market Index Fund

                      •  

                        11,559

                      • 0.00

                      • 0.07

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        2,366

                      • 0.00

                      • 0.01

                      • Fidelity® NASDAQ Composite Index® Fund

                      •  

                        2,273

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Thomson Horstmann & Bryant, Inc.

                      •  

                        837,060

                      • +0.34%

                      • 4.79

                      • Sophrosyne Capital LLC

                      •  

                        550,607

                      • 0.00%

                      • 3.16

                      • Perkins Capital Management Inc

                      •  

                        374,750

                      • 0.00%

                      • 2.15

                      • Pine River Capital Management, L.P.

                      •  

                        331,070

                      • -5.03%

                      • 1.89

                      • Pennsylvania Trust Company

                      •  

                        285,836

                      • +5.54%

                      • 1.64

                      • Fidelity Management and Research Company

                      •  

                        241,250

                      • -60.75%

                      • 1.38

                      • Vanguard Group, Inc.

                      •  

                        145,648

                      • +1.11%

                      • 0.83

                      • Goldman, Sachs & Co.

                      •  

                        103,732

                      • +0.42%

                      • 0.59

                      • Columbia Management Company

                      •  

                        22,843

                      • 0.00%

                      • 0.13

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Distressed

                      Style

                      Small Growth

                      AxoGen, Inc. is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. Peripheral nerves provide the pathways for both motor and sensory signals...more throughout the body and their damage can result in the loss of function and feeling. In order to improve surgical reconstruction and regeneration of peripheral nerves the Company has developed and licensed technologies which are used in its products. Its product portfolio includes Avance Nerve Graft, which the Company believes is the first and only commercially available processed allograft nerve for bridging nerve discontinuities. AxoGuard Nerve Connector, is used as a coaptation aid to facilitate the tensionless repair of severed nerves, and AxoGuard Nerve Protector i...mores used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. The Company’s products are used by surgeons during surgical interventions to repair a wide variety of nerve injuries throughout the body. These injuries range from a simple laceration of a finger to a complex brachial plexus injury (an injury to the network of nerves that originate in the neck) as well as nerve injuries caused by dental and other surgical procedures. Avance Nerve Graft provides surgeons bridging material with the micro-architecture of a human nerve. This structure is essential and allows for bridging nerve gaps or discontinuities up to 70mm in length. Additionally, Avance Nerve Graft has product and sales synergies with AxoGuard Nerve Protector and AxoGuard Nerve Connector. AxoGuard products provide the unique features of pliability, suturability, and translucence for visualization of the underlying nerve, while also allowing the patient’s own cells to incorporate into the extracellular matrix to remodel and form a tissue similar to the outermost layer of the nerve (nerve epineurium). Regenerative medical products enable the repair, restoration, replacement or regeneration of tissue or organ systems of the body. Regenerative medical products are becoming common in various medical arenas because they have been shown to be effective repairing injured or defective tissues, such as bone, tendons, dermis and other tissues of the body. AxoGen’s products are subject to regulation by the FDA, as well as other federal and state regulatory bodies in the U.S. and comparable authorities in other countries.lessless

                      Key People

                      Ms. Karen Zaderej

                      CEO/Director/President

                      Mr. Jamie Grooms

                      Chairman of the Board/Director

                      Mr. Lee Robert Johnston, Jr

                      CFO

                      Shawn F. Mccarrey

                      Vice President, Divisional

                      Mr. John P. Engels

                      Vice President

                      • AxoGen Inc

                      • 13631 Progress Boulevard

                      • Alachua, FL 32615

                      • USA.Map

                      • Phone: +1 386 462-6800

                      • Fax: +1 386 462-6801

                      • axogeninc.com

                      Incorporated

                      0

                      Employees

                      73

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: